A.O. Smith: Great Company, Inferior Investment
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Johnson & Johnson (JNJ) Stock Forecast for 2024–2028. Sell or Buy?
Updated: May 19, 2024 (08:52)
Sector: HealthcareThe share price of Johnson & Johnson (JNJ) now
50/200 Day Moving Average: $152.33 / $156.92
This figure corresponds to the Average Price over the previous 50/200 days. For Johnson & Johnson stocks, the 50-day moving average is the support level today.
For Johnson & Johnson stocks, the 200-day moving average is the resistance level today.
Are you interested in Johnson & Johnson stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Johnson & Johnson stock price in 2024, 2025, 2026, 2027, 2028. How much will one Johnson & Johnson share be worth in 2024 - 2028?
When should I take profit in Johnson & Johnson stock? When should I record a loss on Johnson & Johnson stock? What are analysts' forecasts for Johnson & Johnson stock? What is the future of Johnson & Johnson stock? We forecast Johnson & Johnson stock performance using neural networks based on historical data on Johnson & Johnson stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Johnson & Johnson stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Johnson & Johnson shares. This happens once a day.
Historical and forecast chart of Johnson & Johnson stock
The chart below shows the historical price of Johnson & Johnson stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Johnson & Johnson stock price can be found in the table below.
Long-term forecasts by years.
Unlocking the Future of JNJ: A Strategic Forecast of Stock Movements
As financial landscapes evolve, pinpointing the trajectory of Johnson & Johnson's (JNJ) stock rates becomes a quest for analysts. In the swirling sea of variables, a monumental event stands out: JNJ's acquisition of Shockwave Medical. This move isn't just a new chapter for JNJ; it's a game-changer that significantly impacts JNJ's stock forecast. The introduction of Shockwave's intravascular lithotripsy (IVL) technology to JNJ's portfolio sets the stage for heightened sales, revenue, and an expanding market share in the high-growth cardiovascular intervention arenas.
Decoding Influence: The Path to JNJ's Stock Valuation
To navigate the future JNJ stock forecast, analysts must focus on key drivers. Foremost among these is the strategic acquisition, promising to influence JNJ stock price prediction through bolstered financial health and pioneering technology. Additionally, JNJ's foray into the coronary and peripheral artery disease segments heralds robust growth, advising a strong conviction in 'JNJ stock buy or sell' decisions. Furthermore, the prevention of technological acquisition by rivals spells a significant boon for Johnson & Johnson stock forecast, securing its competitive edge.
For those pondering 'is JNJ a good stock to buy,' the expansive strategy to stave off competition and spearhead growth in untapped markets translates into a compelling argument for investment. Utilizing these insights allows analysts to weave a comprehensive JNJ stock price target, affording investors a clearer vision in their quest for value.
- Shockwave Medical's Acquisition: A beacon in JNJ's stock rate prediction
- Expansion into Cardiovascular Markets: A driver for JNJ stock price prediction
- Prevention of Competition: Central to refining the Johnson & Johnson name stock forecast
In sum, the strategic maneuvers JNJ is making not only redefine its market positioning but also mold the contours of its future stock rates. For analysts and investors alike, these developments offer a fertile ground for making educated predictions on whether to buy or sell Johnson & Johnson stock.
Review the original AnalysisUnpacking the Future: Navigating JNJ's Stock Journey with Insight
In the intricate dance of stock market predictions, few names evoke as much complexity as Johnson & Johnson (JNJ). A behemoth in its domain, JNJ's stock forecast seems perpetually poised on the edge of a knife, balanced by diverse forces. As analysts peer into the crystal ball, a couple of pivotal events stand out in shaping JNJ's financial narrative.
Deciphering JNJ's Stock Market Tapestry
Foremost are the potential legal liabilities tied to talc products. This dark cloud looms large, threatening to sway JNJ stock prices with the gavel's fall. However, the true analyst's art lies in weighing this against JNJ's robust health, marked by strong financial performance and innovative leaps in Medicine and MedTech segments. Herein, the company's vigor is palpable, from its solid earnings to the strategic bet on cardiology technology through the acquisition of Shockwave's groundbreaking technology. Furthermore, the anticipated entry of European biosimilars of Stelara casts a shadow of uncertainty, posing questions around growth momentum.
Yet, for those forecasting JNJ's stock future, understanding the interplay between these factors—legal battles, financial resilience, and market competition—is crucial. By mapping these dynamics against JNJ's historical patterns of strong profitability and free cash flow generation, an analyst can distill a more accurate prediction. The decision to buy or sell JNJ stock, thus, becomes informed by a nuanced understanding of potential headwinds and the company's robust strategic positioning, not least its appeal to income investors following a recent dividend increase.
From this vantage, making a JNJ stock price prediction, setting a target, or deciding on its purchase viability demands a holistic view. Johnson & Johnson's journey is emblematic of the broader market's complexity—a narrative of risk and opportunity, demanding keen insight for navigation.
Review the original AnalysisUnlock the Future of JNJ Stocks: Insights and Predictions
For anyone closely observing the rollercoaster that is the stock market, Johnson & Johnson (JNJ) presents a compelling narrative filled with potential highs and lows. As investors seek to navigate this volatile landscape, understanding the factors poised to impact JNJ stock rates becomes crucial. The key events likely to stir the waters include the launch of biosimilars for Stelara, strenuous competition in the autoimmune disease therapeutics market, and groundbreaking label expansions and drug developments.
Deciphering JNJ's Financial Forecast
Analysts peering into JNJ's future can leverage several critical indicators to forecast the company's stock movement accurately. At the forefront is the sales growth of JNJ's blockbuster and approved drugs, a shining beacon of the company's robust revenue-generating ability. However, looming challenges such as the introduction of biosimilars for Stelara threaten to cast a shadow on this financial powerhouse. Additionally, the competitive environment in the autoimmune disease sector and new drug innovations are significant factors to watch. Not to forget, ongoing legal battles and geopolitical tensions add a layer of unpredictability to JNJ's stock forecast.
By meticulously analyzing these elements, an analyst can craft a nuanced JNJ stock forecast, navigating through the complexities of JNJ stock price predictions with a keen eye on the JNJ stock price target. Whether it’s deciding if JNJ stock is a buy or sell, the journey to making an informed decision is paved with insights into these pivotal events and factors. Thus, understanding their implications is paramount in predicting the future trajectory of Johnson & Johnson's stock, making it an intriguing choice for investors asking, "Is JNJ a good stock to buy?"
- Sales Growth of Key Blockbusters and Approved Drugs
- Impact of Biosimilars for Stelara
- Competition in the Autoimmune Disease Therapeutics Market
- Label Expansion and New Drug Development
- Legal and Geopolitical Risks
If you’re shopping around for top-notch dividend kings to invest in, consider placing Johnson & Johnson (NYSE:JNJ) at the top of your list. For over six decades, this US pharmaceutical titan has been consistently boosting its dividends and currently gifts investors with a quarterly dividend of $1.19 per share. On September 23, it recorded a pretty decent dividend yield of 2.97%.
Recent data suggests that the popularity of Johnson & Johnson (NYSE:JNJ) among hedge funds is on the rise. At the end of Q2 2023, it held a spot in the portfolios of 88 hedge funds, a slight jump from 86 during the previous quarter. What makes this even more significant is that these stakes tally up to a value north of $4.1 billion!
Johnson & Johnson manufactures hygiene products, first aid medicines and medical equipment. Compeed adhesive plasters, Johnson’s Baby care for children, Neutrogena cosmetics, Clean & Clear cleansers and Acuvue contact lenses are the company’s products.
The holding includes 250 companies with three areas of activity: pharmaceuticals, consumer goods and medical equipment manufacturing. Johnson & Johnson products are sold in 175 countries. In 2016, the company earned $ 71.9 billion.
The Johnson brothers originally produced sterile surgical dressings. The first batch went on sale in 1886. Johnson & Johnson’s dressings grew in popularity and were safe and ready to use. In 1916 Johnson & Johnson bought the first textile manufactory. By 1919, the brothers had established a subsidiary in Canada, and by 1924 in the UK. In 1927, the company produced baby cosmetics, feminine hygiene products and adhesive plasters.
Johnson & Johnson daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
May 21 | 155.27 | 154.08 | 156.34 | 1.47 |
May 22 | 156.05 | 155.58 | 157.08 | 0.96 |
May 23 | 154.96 | 153.72 | 156.07 | 1.53 |
May 24 | 154.68 | 153.50 | 155.79 | 1.49 |
May 25 | 155.84 | 154.73 | 156.24 | 0.98 |
May 26 | 156.34 | 155.93 | 156.79 | 0.55 |
May 27 | 156.54 | 156.10 | 157.48 | 0.88 |
May 28 | 156.52 | 155.99 | 157.23 | 0.79 |
May 29 | 157.46 | 156.85 | 157.83 | 0.62 |
May 30 | 157.65 | 157.32 | 157.97 | 0.41 |
May 31 | 156.61 | 155.91 | 156.92 | 0.65 |
Jun 01 | 158.18 | 157.47 | 158.76 | 0.82 |
Jun 02 | 158.92 | 158.43 | 160.13 | 1.07 |
Jun 03 | 160.13 | 159.41 | 161.35 | 1.22 |
Jun 04 | 160.13 | 159.06 | 160.71 | 1.04 |
Jun 05 | 161.60 | 161.13 | 162.33 | 0.74 |
Jun 06 | 161.13 | 160.34 | 161.70 | 0.84 |
Jun 07 | 161.39 | 160.49 | 162.28 | 1.12 |
Jun 08 | 160.28 | 159.17 | 161.46 | 1.44 |
Jun 09 | 160.71 | 160.07 | 161.43 | 0.85 |
Jun 10 | 161.11 | 160.24 | 162.39 | 1.34 |
Jun 11 | 160.19 | 158.96 | 161.06 | 1.32 |
Jun 12 | 160.47 | 159.70 | 161.19 | 0.93 |
Jun 13 | 160.13 | 159.31 | 160.71 | 0.87 |
Jun 14 | 160.98 | 159.74 | 161.80 | 1.29 |
Jun 15 | 161.94 | 161.20 | 162.38 | 0.73 |
Jun 16 | 161.62 | 160.42 | 162.28 | 1.16 |
Jun 17 | 160.76 | 160.35 | 161.68 | 0.83 |
Jun 18 | 159.69 | 158.71 | 160.82 | 1.33 |
Jun 19 | 158.89 | 157.84 | 159.81 | 1.25 |
Johnson & Johnson Daily Price Targets
Johnson & Johnson Stock Forecast 05-21-2024.
Forecast target price for 05-21-2024: $155.27.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.450%.
Pessimistic target level: 154.08
Optimistic target level: 156.34
Johnson & Johnson Stock Forecast 05-22-2024.
Forecast target price for 05-22-2024: $156.05.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 0.954%.
Pessimistic target level: 155.58
Optimistic target level: 157.08
Johnson & Johnson Stock Forecast 05-23-2024.
Forecast target price for 05-23-2024: $154.96.
Negative dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.509%.
Pessimistic target level: 153.72
Optimistic target level: 156.07
Johnson & Johnson Stock Forecast 05-24-2024.
Forecast target price for 05-24-2024: $154.68.
Negative dynamics for Johnson & Johnson shares will prevail with possible volatility of 1.469%.
Pessimistic target level: 153.50
Optimistic target level: 155.79
Johnson & Johnson Stock Forecast 05-25-2024.
Forecast target price for 05-25-2024: $155.84.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 0.967%.
Pessimistic target level: 154.73
Optimistic target level: 156.24
Johnson & Johnson Stock Forecast 05-26-2024.
Forecast target price for 05-26-2024: $156.34.
Positive dynamics for Johnson & Johnson shares will prevail with possible volatility of 0.548%.
Pessimistic target level: 155.93
Optimistic target level: 156.79
JNJ (JNJ) Monthly Stock Prediction for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jun. | 154.08 | 152.56 | 157.46 | 3.11 |
Jul. | 152.05 | 148.49 | 153.10 | 3.01 |
Aug. | 150.09 | 148.24 | 152.34 | 2.69 |
Sep. | 149.19 | 146.82 | 151.96 | 3.39 |
Oct. | 148.29 | 147.31 | 150.52 | 2.13 |
Nov. | 150.61 | 148.12 | 151.55 | 2.27 |
Dec. | 150.02 | 148.71 | 152.45 | 2.45 |
Johnson & Johnson forecast for this year
Johnson & Johnson Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $154.083. Pessimistic: $152.56. Optimistic: $157.46
Johnson & Johnson Stock Prediction for Jul 2024
An downtrend is forecast for this month with an optimal target price of $152.049. Pessimistic: $148.49. Optimistic: $153.10
Johnson & Johnson Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $150.088. Pessimistic: $148.24. Optimistic: $152.34
Johnson & Johnson Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $149.187. Pessimistic: $146.82. Optimistic: $151.96
Johnson & Johnson Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $148.292. Pessimistic: $147.31. Optimistic: $150.52
Johnson & Johnson Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $150.606. Pessimistic: $148.12. Optimistic: $151.55
Johnson & Johnson Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $150.018. Pessimistic: $148.71. Optimistic: $152.45
Johnson & Johnson (JNJ) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 149.25 | 147.06 | 152.34 | 3.47 |
Feb | 150.55 | 148.07 | 152.36 | 2.82 |
Mar | 149.60 | 148.71 | 151.13 | 1.60 |
Apr | 146.64 | 145.28 | 149.19 | 2.62 |
May | 142.99 | 140.03 | 144.88 | 3.35 |
Jun | 143.81 | 140.70 | 147.00 | 4.28 |
Jul | 142.47 | 141.23 | 145.89 | 3.19 |
Aug | 145.08 | 141.81 | 146.25 | 3.04 |
Sep | 145.12 | 142.25 | 146.47 | 2.88 |
Oct | 145.29 | 142.24 | 148.30 | 4.09 |
Nov | 145.25 | 143.11 | 146.64 | 2.41 |
Dec | 146.99 | 145.67 | 148.18 | 1.70 |
Johnson & Johnson (JNJ) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 146.46 | 142.95 | 148.44 | 3.70 |
Feb | 142.11 | 138.74 | 145.23 | 4.46 |
Mar | 143.99 | 142.91 | 145.46 | 1.75 |
Apr | 141.31 | 138.47 | 142.96 | 3.14 |
May | 140.42 | 139.54 | 141.89 | 1.66 |
Jun | 140.84 | 138.01 | 142.32 | 3.03 |
Jul | 141.98 | 139.81 | 143.05 | 2.26 |
Aug | 140.58 | 138.22 | 141.59 | 2.38 |
Sep | 142.69 | 141.53 | 145.85 | 2.96 |
Oct | 139.22 | 135.96 | 141.39 | 3.84 |
Nov | 136.96 | 135.16 | 138.11 | 2.14 |
Dec | 139.02 | 137.81 | 140.89 | 2.19 |
Johnson & Johnson (JNJ) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 138.48 | 136.61 | 141.72 | 3.61 |
Feb | 140.47 | 138.40 | 142.45 | 2.84 |
Mar | 138.57 | 135.33 | 139.70 | 3.12 |
Apr | 137.37 | 135.51 | 138.85 | 2.40 |
May | 139.06 | 136.93 | 140.06 | 2.23 |
Jun | 139.47 | 137.05 | 142.82 | 4.04 |
Jul | 140.77 | 139.34 | 141.95 | 1.84 |
Aug | 142.54 | 139.21 | 145.11 | 4.07 |
Sep | 142.84 | 139.89 | 144.60 | 3.26 |
Oct | 141.64 | 140.71 | 143.47 | 1.93 |
Nov | 140.28 | 138.90 | 143.27 | 3.06 |
Dec | 139.95 | 137.55 | 141.59 | 2.85 |
Johnson & Johnson (JNJ) Monthly Stock Prediction for 2028
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 142.38 | 139.86 | 143.37 | 2.44 |
Feb | 142.68 | 140.97 | 145.64 | 3.20 |
Mar | 145.38 | 142.15 | 147.25 | 3.47 |
Apr | 145.47 | 142.02 | 146.73 | 3.21 |
May | 146.91 | 144.31 | 150.21 | 3.93 |
Jun | 147.26 | 144.61 | 150.17 | 3.71 |
Jul | 149.56 | 148.43 | 150.50 | 1.37 |
Aug | 147.31 | 145.85 | 149.48 | 2.42 |
Sep | 149.26 | 148.05 | 152.57 | 2.96 |
Oct | 148.63 | 147.43 | 151.22 | 2.51 |
Nov | 146.85 | 143.85 | 149.67 | 3.89 |
Dec | 144.91 | 142.52 | 146.56 | 2.76 |
Johnson & Johnson information and performance
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US
Market capitalization of the Johnson & Johnson is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of JNJ shares in the company outstanding by the market price of one share.
EBITDA of Johnson & Johnson is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Johnson & Johnson (JNJ) stock dividend
Johnson & Johnson last paid dividends on 05/20/2024. The next scheduled payment will be on 06/04/2024. The amount of dividends is $4.76 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.